October 2023
1. DARIANE C, Chierigo F, Ouellet V, Delvoye N, et al
   Analysis of active surveillance uptake for localized prostate cancer in Quebec in 2016: A Canadian bicentric study and comparison with 2010 data.
   Prog Urol. 2023 Oct 17:S1166-7087(23)00234-8. doi: 10.1016/j.purol.2023.
   

   >> Share

   
   
2. DANG VT, Pericart S, Manceau C, Aziza R, et al
   Significant prostate cancer risk after MRI-guided biopsy showing benign findings: Results from a cohort of 381 men.
   Prog Urol. 2023 Oct 17:S1166-7087(23)00237-3. doi: 10.1016/j.purol.2023.
   

   >> Share

   
   
3. PEYROTTES A, Roupret M, Fiard G, Fromont G, et al
   [Early detection of prostate cancer: Towards a new paradigm?].
   Prog Urol. 2023 Oct 5:S1166-7087(23)00219-1. doi: 10.1016/j.purol.2023.
   

   >> Share

   
   September 2023
4. BANDELIER Q, Bastide C, Charvet AL, Leclercq L, et al
   Active surveillance in favorable intermediate-risk prostate cancer: A single-center experience.
   Prog Urol. 2023 Sep 30:S1166-7087(23)00227-0. doi: 10.1016/j.purol.2023.
   

   >> Share

   
   
5. DEBARD C, Margue G, Klein C, Rompre-Brodeur A, et al
   [Oncological and functional results of focal treatment of localized prostate cancer with HIFU].
   Prog Urol. 2023 Sep 26:S1166-7087(23)00215-4. doi: 10.1016/j.purol.2023.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share